What is the current annual cash & cash equivalents of BIIB?

As of today, BIIB annual cash & cash equivalents is $2.38B

What is 1-year change in BIIB annual cash & cash equivalents?

BIIB annual cash & cash equivalents is up +126.21% year-over-year

What is 3-year change in BIIB annual cash & cash equivalents?

BIIB annual cash & cash equivalents is up +5.02% over the past 3 years

How far is BIIB annual cash & cash equivalents from its all-time high?

BIIB annual cash & cash equivalents is currently -30.54% below its historical high of $3.42B set on December 31, 2022

How does BIIB annual cash & cash equivalents rank versus sector peers?

BIIB annual cash & cash equivalents is higher than 96.18% of companies in Healthcare sector

When is BIIB next annual earnings release?

The next annual earnings release for BIIB is on February 6, 2026

What is the current quarterly cash & cash equivalents of BIIB?

As of today, BIIB quarterly cash & cash equivalents is $3.96B

What is BIIB quarterly cash & cash equivalents most recent change?

BIIB quarterly cash & cash equivalents was up +43.56% on September 30, 2025

What is 1-year change in BIIB quarterly cash & cash equivalents?

BIIB quarterly cash & cash equivalents is up +133.07% year-over-year

How far is BIIB quarterly cash & cash equivalents from its all-time high?

BIIB quarterly cash & cash equivalents is currently -34.84% below its historical high of $6.08B set on June 30, 2023

How does BIIB quarterly cash & cash equivalents rank versus sector peers?

BIIB quarterly cash & cash equivalents is higher than 97.10% of companies in Healthcare sector

When is BIIB next earnings release?

The next earnings release for BIIB is on February 6, 2026

Biogen Inc. (BIIB) Cash And Cash Equivalents History & Chart

Annual Cash & Cash Equivalents

$2.38B$1.33B+126.21%

December 31, 2024

Summary

Current Value: As of today, BIIB annual cash & cash equivalents is $2.38B, up +126.21% on December 31, 2024
Historical Performance: BIIB annual cash & cash equivalents is up +5.02% over the past 3 years, and down -18.49% over the past 5 years
All-Time High Comparison: BIIB annual cash & cash equivalents is currently -30.54% below its historical high of $3.42B set on December 31, 2022
3-Year Low Comparison: BIIB annual cash & cash equivalents is +126.21% above its 3-year low of $1.05B reached on December 31, 2023
Sector Comparison: BIIB annual cash & cash equivalents is higher than 96.18% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

SUGGESTED SERIES

Performance

BIIB Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 24	$2.38B	+126.2%	+5.0%	-18.5%	+308.1%
Quarterly Cash & Cash Equivalents	Sep 30, 25	$3.96B	+133.1%	-19.4%	+10.6%	+380.3%
Price	Jan 16, 26	$164.42	+16.4%	-42.9%	-40.4%	+147.0%
Annual Current Assets	Dec 31, 24	$7.46B	+8.7%	-5.1%	-11.0%	+200.6%
Annual Total Liabilities	Dec 31, 24	$11.33B	-5.9%	-12.3%	-18.4%	+394.9%
Annual Working Capital	Dec 31, 24	$1.93B	-43.7%	-45.8%	-45.2%	+9.2%
Annual Net Income	Dec 31, 24	$1.63B	+40.5%	-5.5%	–	+67.3%

Cash and Cash Equivalents Highs

BIIB Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$3.42B	N/A	-30.5%
5Y	$3.42B	Dec 31, 22	-30.5%
All	$3.42B	Dec 31, 22	-30.5%

Cash and Cash Equivalents Lows

BIIB Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$1.05B	Dec 31, 23	+126.2%
5Y	$1.05B	Dec 31, 23	+126.2%
All	$12.60M	Dec 31, 90	>+9999.0%

Cash and Cash Equivalents History

Year	Value	Change
2024	$2.38B	+126.2%
2023	$1.05B	-69.3%
2022	$3.42B	+51.2%
2021	$2.26B	+69.9%
2020	$1.33B	-54.3%
2019	$2.91B	+137.9%
2018	$1.22B	-22.2%
2017	$1.57B	-32.4%
2016	$2.33B	+77.9%
2015	$1.31B	+8.6%
2014	$1.20B	+100.0%
2013	$602.56M	+5.6%
2012	$570.72M	+10.9%
2011	$514.54M	-32.3%
2010	$759.60M	+30.5%
2009	$581.89M	-6.5%
2008	$622.39M	-5.7%
2007	$659.66M	-0.3%
2006	$661.38M	+16.4%
2005	$568.17M	+171.3%
2004	$209.45M	-33.5%

Year	Value	Change
2003	$314.85M	-10.1%
2002	$350.13M	+547.9%
2001	$54.04M	+10.9%
2000	$48.74M	-14.4%
1999	$56.92M	+123.7%
1998	$25.45M	-63.8%
1997	$70.36M	+13.4%
1996	$62.03M	+35.5%
1995	$45.77M	-16.3%
1994	$54.68M	-26.6%
1993	$74.50M	-13.3%
1992	$85.90M	+51.8%
1991	$56.60M	+349.2%
1990	$12.60M	-62.0%
1989	$33.20M	-38.9%
1988	$54.30M	-0.2%
1987	$54.40M	-22.8%
1986	$70.50M	+31.8%
1985	$53.50M	-28.6%
1984	$74.90M	-

FAQ

What is the current annual cash & cash equivalents of BIIB?
As of today, BIIB annual cash & cash equivalents is $2.38B
What is 1-year change in BIIB annual cash & cash equivalents?
BIIB annual cash & cash equivalents is up +126.21% year-over-year
What is 3-year change in BIIB annual cash & cash equivalents?
BIIB annual cash & cash equivalents is up +5.02% over the past 3 years
How far is BIIB annual cash & cash equivalents from its all-time high?
BIIB annual cash & cash equivalents is currently -30.54% below its historical high of $3.42B set on December 31, 2022
How does BIIB annual cash & cash equivalents rank versus sector peers?
BIIB annual cash & cash equivalents is higher than 96.18% of companies in Healthcare sector
When is BIIB next annual earnings release?
The next annual earnings release for BIIB is on February 6, 2026

Quarterly Cash & Cash Equivalents

$3.96B$1.20B+43.56%

September 30, 2025

Summary

Current Value: As of today, BIIB quarterly cash & cash equivalents is $3.96B, up +43.56% on September 30, 2025
Historical Performance: BIIB quarterly cash & cash equivalents is up +133.07% year-over-year, and down -19.36% over the past 3 years
All-Time High Comparison: BIIB quarterly cash & cash equivalents is currently -34.84% below its historical high of $6.08B set on June 30, 2023
3-Year Low Comparison: BIIB quarterly cash & cash equivalents is +277.22% above its 3-year low of $1.05B reached on December 31, 2023
Sector Comparison: BIIB quarterly cash & cash equivalents is higher than 97.10% of companies in Healthcare sector

Performance

BIIB Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 25	$3.96B	+43.6%	+133.1%	-19.4%	+10.6%
Annual Cash & Cash Equivalents	Dec 31, 24	$2.38B	–	+126.2%	+5.0%	-18.5%
Price	Jan 16, 26	$164.42	+15.6%	+16.4%	-42.9%	-40.4%
Quarterly Current Assets	Sep 30, 25	$8.94B	+12.2%	+30.8%	-8.5%	+13.9%
Quarterly Total Liabilities	Sep 30, 25	$11.00B	+2.8%	-8.0%	-9.0%	-22.5%
Quarterly Working Capital	Sep 30, 25	$5.65B	+18.0%	+301.8%	-3.3%	+39.8%
Quarterly Net Income	Sep 30, 25	$466.50M	-26.5%	+20.1%	-58.9%	-33.7%

Quarterly Cash & Cash Equivalents Highs

BIIB Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$3.96B	Sep 30, 25	at high
3Y	$6.08B	Jun 30, 23	-34.8%
5Y	$6.08B	Jun 30, 23	-34.8%
All	$6.08B	Jun 30, 23	-34.8%

Quarterly Cash & Cash Equivalents Lows

BIIB Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$2.38B	N/A	+66.8%
3Y	$1.05B	Dec 31, 23	+277.2%
5Y	$1.05B	Dec 31, 23	+277.2%
All	$3.50M	Jun 30, 91	>+9999.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2025	$3.96B	+43.6%
Jun 2025	$2.76B	+6.2%
Mar 2025	$2.60B	+9.4%
Dec 2024	$2.38B	+39.8%
Sep 2024	$1.70B	-11.0%
Jun 2024	$1.91B	+77.7%
Mar 2024	$1.07B	+2.3%
Dec 2023	$1.05B	-54.1%
Sep 2023	$2.29B	-62.4%
Jun 2023	$6.08B	+20.6%
Mar 2023	$5.04B	+3.0%
Dec 2022	$4.89B	-0.4%
Sep 2022	$4.91B	+2.4%
Jun 2022	$4.80B	+27.9%
Mar 2022	$3.75B	-1.3%
Dec 2021	$3.80B	+28.7%
Sep 2021	$2.96B	-3.1%
Jun 2021	$3.05B	+20.2%
Mar 2021	$2.54B	-2.8%
Dec 2020	$2.61B	-27.1%
Sep 2020	$3.58B	-17.3%
Jun 2020	$4.33B	+12.1%
Mar 2020	$3.86B	-13.8%
Dec 2019	$4.48B	+0.9%
Sep 2019	$4.44B	+50.3%
Jun 2019	$2.95B	-24.5%
Mar 2019	$3.91B	+10.5%
Dec 2018	$3.54B	-20.1%
Sep 2018	$4.43B	+37.3%
Jun 2018	$3.22B	-45.5%
Mar 2018	$5.92B	+60.4%
Dec 2017	$3.69B	+5.2%
Sep 2017	$3.51B	+21.3%
Jun 2017	$2.89B	+0.4%
Mar 2017	$2.88B	-41.2%
Dec 2016	$4.90B	+13.4%
Sep 2016	$4.32B	+13.7%
Jun 2016	$3.80B	+5.9%
Mar 2016	$3.59B	+4.6%
Dec 2015	$3.43B	-41.3%
Sep 2015	$5.84B	+146.7%
Jun 2015	$2.37B	+10.1%
Mar 2015	$2.15B	+16.6%
Dec 2014	$1.85B	-0.9%
Sep 2014	$1.86B	+18.3%
Jun 2014	$1.57B	+24.8%
Mar 2014	$1.26B	+3.1%
Dec 2013	$1.22B	+82.9%
Sep 2013	$668.69M	+0.2%
Jun 2013	$667.67M	-81.6%
Mar 2013	$3.63B	+112.9%
Dec 2012	$1.71B	+6.2%
Sep 2012	$1.61B	+14.2%
Jun 2012	$1.41B	+10.1%
Mar 2012	$1.28B	-26.2%
Dec 2011	$1.73B	+12.5%
Sep 2011	$1.54B	+16.0%
Jun 2011	$1.33B	+8.0%
Mar 2011	$1.23B	+1.7%
Dec 2010	$1.21B	+46.5%
Sep 2010	$824.59M	-15.0%
Jun 2010	$969.67M	-15.9%
Mar 2010	$1.15B	-8.8%
Dec 2009	$1.26B	-10.2%
Sep 2009	$1.41B	-13.3%
Jun 2009	$1.62B	+15.8%
Mar 2009	$1.40B	+2.2%
Dec 2008	$1.37B	-1.1%
Sep 2008	$1.39B	+55.4%
Jun 2008	$892.25M	-9.5%
Mar 2008	$986.40M	-16.7%
Dec 2007	$1.18B	+76.3%
Sep 2007	$671.35M	-62.8%
Jun 2007	$1.80B	+59.9%

Month	Value	Change
Mar 2007	$1.13B	+24.9%
Dec 2006	$902.69M	+36.6%
Sep 2006	$661.02M	-7.4%
Jun 2006	$713.77M	-16.0%
Mar 2006	$849.36M	-0.2%
Dec 2005	$850.75M	+39.1%
Sep 2005	$611.40M	-34.1%
Jun 2005	$927.45M	-19.5%
Mar 2005	$1.15B	+8.9%
Dec 2004	$1.06B	+137.3%
Sep 2004	$445.88M	-39.9%
Jun 2004	$741.38M	-2.6%
Mar 2004	$761.55M	-8.9%
Dec 2003	$835.96M	-1.4%
Sep 2003	$847.58M	+14.9%
Jun 2003	$737.63M	-14.2%
Mar 2003	$859.98M	+9.2%
Dec 2002	$787.77M	-16.8%
Sep 2002	$947.28M	-9.7%
Jun 2002	$1.05B	+118.7%
Mar 2002	$479.49M	-23.1%
Dec 2001	$623.82M	+8.2%
Sep 2001	$576.37M	-5.9%
Jun 2001	$612.52M	-3.7%
Mar 2001	$635.86M	+131.2%
Sep 2000	$274.98M	+0.3%
Jun 2000	$274.26M	+3.4%
Mar 2000	$265.17M	+15.3%
Sep 1999	$229.99M	+7.9%
Jun 1999	$213.19M	+8.7%
Mar 1999	$196.06M	+200.5%
Sep 1998	$65.24M	-7.4%
Jun 1998	$70.47M	+11.1%
Mar 1998	$63.41M	-9.9%
Dec 1997	$70.36M	+12.4%
Sep 1997	$62.60M	-14.6%
Jun 1997	$73.30M	-27.8%
Mar 1997	$101.50M	+63.6%
Dec 1996	$62.03M	-0.9%
Sep 1996	$62.60M	+25.0%
Jun 1996	$50.10M	+54.2%
Mar 1996	$32.50M	-29.0%
Dec 1995	$45.77M	-12.8%
Sep 1995	$52.50M	+12.4%
Jun 1995	$46.70M	-31.7%
Mar 1995	$68.40M	+25.1%
Dec 1994	$54.68M	-16.5%
Sep 1994	$65.50M	+67.5%
Jun 1994	$39.10M	-25.8%
Mar 1994	$52.70M	-29.3%
Dec 1993	$74.50M	-0.5%
Sep 1993	$74.90M	-3.0%
Jun 1993	$77.20M	+62.9%
Mar 1993	$47.40M	-44.8%
Dec 1992	$85.90M	+13.9%
Sep 1992	$75.40M	+104.9%
Jun 1992	$36.80M	-5.2%
Mar 1992	$38.80M	-31.4%
Dec 1991	$56.60M	+177.5%
Sep 1991	$20.40M	+482.9%
Jun 1991	$3.50M	-79.5%
Mar 1991	$17.10M	+35.7%
Dec 1990	$12.60M	-13.1%
Sep 1990	$14.50M	-15.7%
Jun 1990	$17.20M	+20.3%
Mar 1990	$14.30M	-56.9%
Dec 1989	$33.20M	+2.8%
Sep 1989	$32.30M	-40.5%
Dec 1988	$54.30M	-0.2%
Dec 1987	$54.40M	-22.8%
Dec 1986	$70.50M	+31.8%
Dec 1985	$53.50M	-28.6%
Dec 1984	$74.90M	-

FAQ

What is the current quarterly cash & cash equivalents of BIIB?
As of today, BIIB quarterly cash & cash equivalents is $3.96B
What is BIIB quarterly cash & cash equivalents most recent change?
BIIB quarterly cash & cash equivalents was up +43.56% on September 30, 2025
What is 1-year change in BIIB quarterly cash & cash equivalents?
BIIB quarterly cash & cash equivalents is up +133.07% year-over-year
How far is BIIB quarterly cash & cash equivalents from its all-time high?
BIIB quarterly cash & cash equivalents is currently -34.84% below its historical high of $6.08B set on June 30, 2023
How does BIIB quarterly cash & cash equivalents rank versus sector peers?
BIIB quarterly cash & cash equivalents is higher than 97.10% of companies in Healthcare sector
When is BIIB next earnings release?
The next earnings release for BIIB is on February 6, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

BIIB Official Website www.biogen.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875045/000087504525000049/0000875045-25-000049-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875045/000087504525000009/0000875045-25-000009-index.htm
BIIB Profile on Yahoo Finance finance.yahoo.com/quote/BIIB
BIIB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/biib